Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income
Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income
Ayurcann Holdings Corp. (CSE:AYUR) (FSE: 3ZQ0) a Toronto-based cannabis extraction company specializing in processing and manufacturing cannabis products, reported its financial and operating results for the three months ended September 30, 2021, in a press release on Monday, Nov. 29.
阿尤坎控股公司(Ayurcann Holdings Corp.)多倫多一家專門加工和製造大麻產品的大麻提取公司(CSE：AYUR)(FSE：3ZQ0)在11月29日(星期一)的一份新聞稿中報告了截至2021年9月30日的三個月的財務和經營業績。
Highlights For The First Quarter Ended September 30, 2021
截至2021年9月30日的第一季度亮點
- Ayurcann reported net revenues of C$1.9 million for the three months ended September 30, 2021, compared to C$ 0.8 million for the same period in 2020, an increase of 137% year-over-year.
- The Company reported gross margins of C$931,000 for the three months ended September 30, 2021 (compared to C$169,000 for the three months ended September 30, 2020) with gross margins of 49%, maintaining strong control over sales and profitability.
- 阿尤爾坎已報告淨收入截至2021年9月30日的三個月為190萬加元，而2020年同期為80萬加元，增長了同比增長137%.
- 該公司報告毛利率截至2021年9月30日的三個月為931,000加元(而截至2020年9月30日的三個月為169,000加元)，毛利率為49%，保持對銷售和盈利的強大控制。
Ayurcann finished its build-out of the Phase-2 expansion of the Pickering facility, increasing extraction capacity up to 300,000 kilograms of input biomass and up to three million filled and co-packaging capacity for cannabis 2.0 and 3.0 products, providing Canadian licensed producers with a one-stop extraction facility and offering international brands seeking a go-to-market strategy, announced the firm in a release.
Ayurcann完成了Pickering設施二期擴建項目的擴建，將提取能力提高到30萬公斤投入生物質該公司在一份新聞稿中宣佈，大麻2.0和3.0產品的灌裝和聯合包裝能力高達300萬，為加拿大獲得許可的生產商提供了一站式提取設施，併為尋求上市戰略的國際品牌提供了服務。
The Canadian cannabis firm maintains an inventory of approximately 300 kilograms of crude THC and CBD distillate and pharma-grade isolate available for its co-manufacturing and white label partnerships.
這家加拿大大麻公司擁有大約300公斤粗製THC和CBD餾分以及製藥級分離物的庫存，可供其聯合制造和白標合作伙伴使用。
The Company is expanding into various recreational markets throughout Canada and announced that cannabis 2.0 products, with Fuego-branded vapes and Vida-branded tinctures were shipped to New Brunswick and Saskatchewan, with Ayurcann produced products for the health and wellness segment, including its Glow-branded topical cannabis products available throughout Ontario.
該公司正在向加拿大各地的各種娛樂市場擴張，並宣佈大麻2.0產品，包括福伊戈品牌Vapes和Vida品牌的酊劑被運往新不倫瑞克和薩斯喀徹温省，Ayurcann為健康和健康領域生產產品，包括其輝光品牌安大略省各地都能買到外用大麻產品。
Health and wellness is a growing segment of the cannabis market in Canada, and Ayurcann, along with its partners Green Bee (California, USA), Her Highness (New York, USA) and Innocan Pharma (Israel) are creating products to meet the demand of Canadian consumers.
健康和健康是加拿大大麻市場日益增長的一部分，阿尤坎及其合作伙伴綠蜂(美國加利福尼亞州)、殿下(美國紐約)和Innocan Pharma(以色列)正在開發滿足加拿大消費者需求的產品。
"This quarter has proven again that Ayurcann is able to achieve profitability and expand its market share. Ayurcann serves its clients and continues to grow its revenues while keeping an eye on its bottom line, and acting in a manner which is responsible towards its shareholders and other stakeholders," Igal Sudman, CEO of Ayurcann said in the release
“本季度再次證明，Ayurcann能夠實現盈利並擴大市場份額。Ayurcann為客户服務，並在關注利潤的同時繼續增長收入，並以對股東和其他利益相關者負責的方式行事。”伊格爾·薩德曼,阿尤坎首席執行官在新聞稿中説
"We are thrilled to see our revenues grow at a steady pace while maintaining incredibly strong margins and running a profitable business. We can confidently say we are profitable now and fully expect to show continued profits going forward while building on our momentum," Sudman added.
薩德曼補充説：“我們很高興看到我們的收入以穩定的速度增長，同時保持着令人難以置信的強勁利潤率，並經營着一項盈利的業務。我們可以自信地説，我們現在是盈利的，我們完全預計，在發展勢頭的同時，我們將繼續盈利。”
Price Action
價格行動
AYUR traded 6.25% lower at C$0.15 per share, at the time of writing, Monday afternoon.
阿尤爾交易下跌6.25%，至每股0.15加元。，在撰寫本文時，星期一下午。
Image By Ilona Szentivanyi
圖片由Ilona Szentivanyi提供
譯文內容由第三人軟體翻譯。